Citigroup Inc Exact Sciences Corp Put Options Transaction History

Citigroup Inc

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 12, 2024	SELL	$42.43 - $70.83 $7.74 Million - $12.9 Million	-182,500 Reduced 97.33%	5,000 $340,000
Q2 2024 Aug 12, 2024	SELL	$41.33 - $74.26 $326,507 - $586,654	-7,900 Reduced 4.04%	187,500 $7.92 Million
Q1 2024 May 10, 2024	BUY	$56.27 - $73.77 $11 Million - $14.4 Million	195,400 New	195,400 $13.5 Million
Q4 2022 Feb 09, 2023	BUY	$30.35 - $53.15 $482,565 - $845,085	15,900 Added 46.63%	50,000 $2.48 Million
Q3 2022 Nov 10, 2022	BUY	$31.97 - $49.37 $450,777 - $696,117	14,100 Added 70.5%	34,100 $1.11 Million
Q2 2022 Aug 10, 2022	BUY	$35.61 - $76.23 $712,200 - $1.52 Million	20,000 New	20,000 $788,000

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.